Abstract
Glucose, the principal regulator of endocrine pancreas, has several effects on pancreatic beta cells, including the regulation of insulin release, cell proliferation, apoptosis, differentiation, and gene expression. Although the sequence of events linking glycemia with insulin release is well described, the mechanism whereby glucose regulates nuclear function is still largely unknown. Here, we have shown that an ATP-sensitive K+ channel (KATP) with similar properties to that found on the plasma membrane is also present on the nuclear envelope of pancreatic beta cells. In isolated nuclei, blockade of the KATP channel with tolbutamide or diadenosine polyphosphates triggers nuclear Ca2+ transients and induces phosphorylation of the transcription factor cAMP response element binding protein. In whole cells, fluorescence in situ hybridization revealed that these Ca2+ signals may trigger c-myc expression. These results demonstrate a functional KATP channel in nuclei linking glucose metabolism, nuclear Ca2+ signals, and nuclear function.
Pancreatic beta cells play a critical role in maintaining a steady-state level of glucose in the blood and tissues. Increased levels of glucose stimulate beta cells to secrete insulin closing a well established feedback loop. Malfunction of beta cells causes the widespread pathology, diabetes mellitus. The signal transduction mechanism leading to insulin release involves the closure of plasma membrane KATP channels as a result of glucose metabolism by increasing both the intracellular ATP/ADP ratio and diadenosine polyphosphates (DPs; refs. 1 and 2). Channel closure leads to membrane depolarization and the opening of voltage-activated Ca2+ channels (3). The subsequent cytosolic Ca2+ signal, which is oscillatory (4), triggers a pulsatile insulin secretion. In most cells, a single second messenger as Ca2+ is able to provoke different responses depending on its route of entry, its localization, and a code of amplitude or frequency of Ca2+ oscillations (4, 5). In pancreatic beta cells, Ca2+ mediates not only insulin secretion but also a broad range of other processes such as gene expression (6, 7). Although it is well established that the nucleoplasmic concentration of free Ca2+ regulates nuclear function (5), the mechanism whereby nuclear Ca2+ signals are generated is still unclear. Here, we report confocal measurements of nuclear Ca2+ concentration ([Ca2+]n) in intact beta cells exposed to glucose. Experiments in isolated nuclei revealed a KATP channel present on the nuclear envelope whose blockade results in a [Ca2+]n rise. This increased [Ca2+]n induces phosphorylation of the transcription factor cAMP response element binding protein (CREB). We further demonstrate that [Ca2+]n elevation may result in c-myc expression in whole cells.
Materials and Methods
Cell Isolation, Culture, and Permeabilization.
Islets from adult (8–10 weeks old) Swiss albino male mice (OF1) killed by cervical dislocation were isolated and then dispersed into single cells after a published procedure (3). Isolated cells were cultured in RPMI medium 1640 for 24 h. Cell permeabilization was performed as described (8).
Spot Confocal Microscopy.
Cells were loaded with 2 μM Calcium Green-1/AM (Molecular Probes) for 60 min at room temperature (RT) and then were perfused in a modified Krebs–Ringer buffer [119 mM NaCl/4.7 mM KCl/1.2 mM MgSO4/1.2 mM KH2PO4/25 mM NaHCO3/2.5 mM CaCl2/3 mM glucose bubbled constantly with a mixture of 95% O2/5% CO2 (pH = 7.4)]. Ca2+ was measured by using spot confocal microscopy, which excels in measuring minute Ca2+ transients because of its high signal-to-noise ratio. The spot illumination-detection configuration has been described (9, 10). Briefly, a laser-illuminated pinhole (10 μm) was focused onto a spot through the objective on a nucleus equatorial plane. Thus, the predicted detection volume is about 0.6 × 0.6 × 1.1 μm3. Changes in fluorescence in this nuclear volume were precisely detected with a photodiode (HR008; United Detector Technology) which was connected to an Axopatch-200A amplifier (50 GΩ feedback; Axon Instruments, Foster City, CA). The laser illumination time was 30 ms. Ca2+-induced fluorescence intensity ratio was plotted as a function of time (Ft/F0).
Nuclei Isolation.
While dispersed, islet cells were suspended in a buffer that mimicked the intracellular medium (125 mM KCl/2 mM K2P04/40 mM Hepes/0.1 mM MgCl2, pH 7.2/100 nM Ca2+, with 10.2 mM EGTA and 1.65 mM CaCl2). The cell membrane and cytoskeleton were disrupted by brief sonication. Single isolated nuclei were separated by centrifugation, resuspended in the intracellular medium, and then allowed to attach onto glass chambers (11). Ethidium homodimer-1 labeling (Molecular Probes) indicated that the suspension was 90% enriched in nuclei. This probe also was applied to identify nuclei after each electrophysiological and imaging experiment. An antibody to calnexin allowed an assessment of contamination of the nuclei preparation with endoplasmic reticulum (ER) fragments (12). We further performed confocal images and three-dimensional (3D) reconstruction of nuclei labeled with rhodamine B hexyl ester to detect the existence of some debris attached to the surface of some nuclei (10%), which was associated with ER contamination (13, 14). As this ER debris was completely detectable by transmitted light or fluorescence microscopy, we only performed experiments in intact and clean nuclei (free of debris).
Glibenclamide-Dipyrrometheneboron Difluoride (BODIPY) Staining.
Cultured isolated islet cells were labeled with 40 nM of green-fluorescent glibenclamide-BODIPY-FL (30 min at 4°C; Molecular Probes) and stained with anti-insulin antibodies (15). Immunofluorescence for insulin revealed more than 80% of pancreatic beta cells in the cultures. Isolated nuclei also were stained with glibenclamide-BODIPY-FL following the same protocol. Nuclear envelope was identified with 1 μM of rhodamine B hexyl ester (5 min at RT; Molecular Probes; ref. 14); meanwhile, 1 μM of ethidium homodimer-1 (5 min at RT; Molecular Probes) stained the DNA containing nucleoplasm. Fluorescence was visualized by using a Zeiss LSM 510 confocal microscope (63× objective, 1.25 N.A.) and 1–2 μm optical slices. Intensity values were obtained by calculating the average brightness value on the corresponding ring-like staining of the nuclei and measured on an arbitrary gray scale from 0 (blackest) to 255 (whitest).
Patch-Clamp Experiments.
Single-channel currents were recorded from nuclei positively labeled with ethidium homodimer-1 by using standard patch-clamp recording procedures (16). The bath solution contained 140 mM KCl, 1 mM MgCl2, 10 mM Hepes, 1 mM EGTA, pH 7.2, and the pipette solution contained 5 mM KCl, 135 mM NaCl, 10 mM Hepes, 1.1 mM MgCl2, pH 7.4. Pipette potential was held at 0 mV throughout the record. Experiments were performed at RT. High resistance seals were formed (1–5 GΩ), indicating minimal contamination by the endoplasmic reticulum (ER) membrane (13). Under these circumstances, it has been proposed that nuclear pores would be occluded or nonconducting because of experimental conditions or lack of cytosolic factors (13, 14, 17).
Ca2+ Measurements in Isolated Nuclei.
Single isolated nuclei were loaded as described (11, 18). The membrane impermeant Ca2+ probe Calcium Green-1 dextran (30 μg/ml; 30 min at 4°C; Molecular Probes) loaded the nucleoplasm while the membrane permeant Ca2+ probe Fluo-3/AM (20 μM; 60 min at 4°C) loaded the nuclear envelope. After loading, the nuclei were washed twice with the intracellular medium and then were equilibrated in the same medium supplemented with 1 μM of ATP and 300 nM Ca2+ for a few minutes to load nuclei with Ca2+ (11, 18). After that, they were washed twice again with the intracellular buffer (without ATP and Ca2+). Experiments were done at RT. No probe leakage was detected during the experiment. Ca2+ imaging in single isolated nuclei was performed by using a Zeiss LSM 510 confocal microscope with a Zeiss 63X oil immersion lens, N.A. 1.25. Images were collected at 3 s intervals, and fluorescence was measured by using the Zeiss LSM software package. Ca2+-induced fluorescence intensity ratio (Ft/F0) was plotted as a function of time.
Nuclear Transmembrane Potential (ΔΨn) Measurements.
Isolated nuclei were equilibrated in intracellular medium containing the ER marker DiOC6(3) (200 nM, RT; ref. 19). After 5 min, the nuclear envelope became stained. DiOC6(3) is a fluorescent cationic lipophyllic dye whose incorporation into lumen is proportional to ΔΨ.
P-CREB Immunofluorescence.
CREB phosphorylation was induced in isolated nuclei by increasing Ca2+ in an EGTA-buffered intracellular medium from 65 nM to 1 μM Ca2+ (20) or by addition of tolbutamide or AP4A for 2 min. After 10 min, nuclei were fixed with 0.1% paraformaldehyde (wt/vol) and permeabilized with 0.1% Triton X-100 for 10 min. Nuclei were preincubated with blocking buffer; then, anti-CREB phospho-specific rabbit antibodies were applied for 16 h at 4°C (1:200, Calbiochem). P-CREB was visualized with fluorescein-conjugated secondary antibodies (1 h, RT, 1:64; Sigma). High Ca2+ gave the maximum response.
Fluorescence in Situ Hybridization.
Fragments (237 and 530 bp) of c-myc and β-actin cDNAs cloned in pBSSK (Stratagene) were used as templates for digoxigenin-labeled double-stranded DNA probes, synthesized by PCR using specific primers (21, 22). Isolated islet cells were cultured at least for 24 h in a culture medium containing 3 mM of glucose and then were placed in different stimulating conditions in a Krebs–Ringer buffer for 10 min. After that, cells were equilibrated in 3 mM of glucose for 45 min. Only when AP4A was used as a stimulator, cells were permeabilized as mentioned above. Then, cells were fixed in a solution containing 4% (vol/vol) formaldehyde, 5% (vol/vol) acetic acid, and 0.9% NaCl and permeabilized with 1:1,000 Triton X-100 for 10 min. Hybridization was performed under standard conditions and was revealed by immunofluorescence detection with fluorescein-conjugated antidigoxigenin (1:500; Roche, Barcelona, Spain). Nonspecific binding was reduced with a commercial blocking reagent (Roche, Barcelona, Spain). Cells were counterstained with 1 μM ethidium homodimer for 5 min before visualization under a Zeiss LSM 510 confocal microscope (10× objective, 0.45 N.A.). The average intensity value from each stained cell was calculated and expressed on an arbitrary gray scale from 0 (blackest) to 255 (whitest). Cells whose fluorescence intensity was above the range of values of unstimulated control cells were scored as activated cells for gene expression.
Statistical Analysis.
Statistical analysis was performed by using SIGMAPLOT (Jandel, San Rafael, CA). Values are mean ± SE. Except where indicated, P < 0.05 by Student's t test.
Results
Nuclear Ca2+ Changes.
Ca2+ changes were measured in the nuclear space of isolated pancreatic beta cells by spot confocal microscopy (Fig. 1A; refs. 9 and 10). Cells equilibrated in an extracellular medium containing 16.7 mM glucose exhibited a transient increase of [Ca2+]n (Fig. 1B). Exposure to the sulfonylurea tolbutamide (20 μM), which directly closes KATP channels, produced a similar increase (Fig. 1B). Both increases of [Ca2+]n were still produced in the absence of extracellular Ca2+ (Fig. 1C). Increased [Ca2+]n was probably due to direct Ca2+ release from the nuclear envelope to the nuclear space (11, 14, 23), because tolbutamide induces [Ca2+]n changes not only in the absence of extracellular Ca2+ but in digitonin permeabilized cells (8) with a buffered Ca2+ concentration (Fig. 1D). The tolbutamide-induced Ca2+ increase was counteracted by the sulfonamide diazoxide, a KATP channel opener (Fig. 1D). These results strongly suggest that intracellular KATP channels responsible for eliciting nuclear Ca2+ signals might be present close to the beta cell nucleus.
Figure 1.
Ca2+ changes in the nuclear space in intact cells revealed by spot confocal microscopy. (A) Hybrid phase contrast image with a fluorescent spot (see arrow) focused on an intact cell nucleus loaded with Calcium-Green-1/AM. (B) Intact cells were stimulated with different agents at the time indicated by the line. Values are mean ± SE and were pooled from six cells [16.7 mM glucose (G)] and seven cells [20 μM tolbutamide (T)]. (C) Beta cells were stimulated with 16.7 mM G (n = 5) and 20 μM T (n = 6) in a Ca2+-buffered medium containing 5 mM EGTA. (D) Permeabilized cells were stimulated with 100 μM tolbutamide or 100 μM tolbutamide plus 100 μM diazoxide (n = 4) in a Ca2+-buffered intracellular medium. G, glucose; T, tolbutamide; D, diazoxide.
Verification of KATP Channels on Nuclei.
To verify the existence of a KATP channel on the nuclear envelope from mouse beta cells, we used a high-specificity, high-affinity (Kis = 4 nM) binding assay of glibenclamide-BODIPY-FL to the sulfonylurea receptor (SUR1; ref. 14). SUR1 is the molecular complement of the potassium inward rectifier (Kir; refs. 24 and 25). The association of SUR1 and Kir6.2 forms the KATP channel in beta cells. Fig. 2 A–C shows a confocal optical section of pancreatic beta cells with an intracellular ring-like labeling, suggesting the binding of glibenclamide-BODIPY to the nuclear envelope. Similar results were observed in isolated nuclei (Fig. 2 D–F). The glibenclamide-BODIPY binding site colocalized with rhodamine B hexyl ester, a marker of the nuclear membrane (ref. 14; Fig. 2E). The binding was specific because it was displaced by the nonfluorescent sulfonylurea tolbutamide in a dose-dependent manner (Fig. 2G). This evidence agrees with previous observations reporting an intracellular location of KATP channels including perinuclear sites (26–31) in addition to plasma membrane KATP channels.
Figure 2.

KATP channels on the nuclear envelope. (A) Intact islet cells incubated with glibenclamide-BODIPY-FL showed a strong ring-like labeling around the nucleus. (B) Cell in A identified as beta cell by immunofluorescence against insulin. (C) Colocalization of images A and B. Optical sections range between 1–2 μm. (Bar = 10 μm.) Similar results were obtained in 19 cells from four coverslips from three different cultures. (D) Glibenclamide-BODIPY-FL ring-like staining of an isolated nucleus. (E) Nucleus in D with rhodamine B hexyl ester staining the nuclear envelope. (F) Colocalization of images D and E (n = 21). (Bar = 5 μm.) Confocal images were taken with 1 μm optical slices. (G) Glibenclamide-BODIPY competition with nonfluorescent unlabeled tolbutamide reflected a displacement of the binding site at the nuclear envelope. Glibenclamide labeling is expressed as the percentage of fluorescence intensity with respect to the control condition (0 μM tolbutamide). Results (mean ± SE) were pooled from 94 nuclei for 0 μM tolbutamide, 29 for 1 μM, 20 for 10 μM, and 24 for 1.000 μM from 12 coverslips of 6 different nuclei preparations. (H) Image showing a patch pipette on an isolated nucleus previously identified using ethidium homodimer-1. (I) Single-channel records (filtered at 1 KHz) were obtained from a nucleus membrane excised patch (n = 5). The pipette potential was held at 0 mV. Upward currents represent currents going into the pipette. Single-channel current gives an estimate of 25 pS. A dashed line represents changes in the external solution. (i) ADP (200 μM) increased the burst length. The change from 200 μM ADP to 2 mM ATP rapidly and completely closed K+ channels. (ii) The K+ channel activity absent in 2 mM ATP was rapidly restored when ATP was removed. (iii) The change from 40 μM to 20 μM ATP increased channel activity. (iv) Diazoxide (200 μM) activates the channel in the presence of ATP, whereas tolbutamide (100 μM) blocks it.
Excised patch-clamp recordings (16) from the nuclear envelope of isolated nuclei in a 140 mM K+/5 mM K+ solution exhibited K+-channel activity with conductance of approximately 25 pS (ref. 25; Fig. 2I). This channel was activated by ADP and inhibited by ATP in a concentration-dependent manner (Fig. 2I). Nuclear KATP (nKATP) channels display kinetic properties similar to channels found on the beta cell plasma membrane, with openings grouped in bursts separated by long closing periods (data not shown). The pharmacological profile of the nKATP channel also resembles that of the plasma membrane KATP channel (25). At concentrations similar to those acting on the plasma membrane KATP channel, tolbutamide (100 μM) blocks the nKATP channel whereas diazoxide (200 μM) opens it (Fig. 2Iiv) in the presence of ATP. Therefore, this nKATP channel seems remarkably similar to the plasma membrane KATP channel (25).
Blockade of nKATP Channels Elicits Ca2+ Signals in Isolated Nuclei.
Depending upon their lipophylicity, the Ca2+-sensitive fluorescence dyes Fluo-3/AM or Calcium Green-1 dextran localized preferably in the nuclear envelope or the nucleoplasm (11, 14, 18), respectively (Fig. 3 A and B). In isolated nuclei, confocal microscopy revealed that tolbutamide induced opposite Ca2+ changes in the nuclear envelope and the nucleoplasm (Fig. 3 A and B). Either 100 μM or 500 μM of tolbutamide generated Ca2+ increases in the nucleoplasm, which paralleled Ca2+ decreases observed in the nuclear envelope (Fig. 3 A and B). Tolbutamide did not produce any Ca2+ transient in the presence of the KATP channel opener diazoxide (data not shown). Moreover, the diadenosine polyphosphate AP4A (100 μM), which blocks the KATP channel (2), induced a similar Ca2+ release (Fig. 3C). Because AP4A is membrane-impermeant, this experiment also suggests that the regulatory site of this K+ channel does not face the perinuclear space. Thus, the nuclear envelope may act as a Ca2+ reservoir that is mobilized as a result of glucose metabolism.
Figure 3.

Nuclear Ca2+ signals induced by KATP channel blockade. (A) Nuclei were loaded with the membrane permeant probe Fluo-3/AM, which was preferentially accumulated in the nuclear envelope (ref. 11; see image). [Ca2+]n was measured by using confocal microscopy. Tolbutamide applied to Fluo-3-loaded nuclei produced a Ca2+ decrease (n = 3). (B) Calcium Green-1 dextran, a nonpermeant probe, was distributed uniformly in the nucleoplasm (see image). Tolbutamide provoked a transient Ca2+ increase in the nucleoplasm (n = 6). Spot confocal methods also were used to observe this tolbutamide-induced nuclear Ca2+ release (n = 3; data not shown). (Bar = 5 μm.) (C) Same experiment described in B showing a Ca2+ release induced by 100 μM AP4A (n = 3). (D) Replacement of 100 mM K+ by NMG+ (N-methyl-d-glucamine) led to a similar Ca2+ transient (n = 4) in the nucleoplasm. (E) Nuclear envelope was loaded with DiOC6(3), a voltage-sensitive probe (see Materials and Methods). Fluorescence was increased upon addition of tolbutamide (n = 4). (F) Ruthenium red (RR) blocked almost 90% of the tolbutamide-induced Ca2+ release (n = 4). Two consecutive Ca2+ transients were induced in this experiment. Before the second discharge, nuclei were loaded with Ca2+ (see Materials and Methods) and then treated with ruthenium red. When the blocker was not present, the two transients had the same amplitude. Thus, the first transient was used as a control (C).
All of these results suggested that this Ca2+ pool was sensitive to changes in the nuclear membrane K+ permeability but also raised the possibility that Ca2+ release may be elicited by means of a voltage-dependent mechanism. To explore the hypothesis that blockade of nKATP channels provokes a Ca2+ release from the nuclear envelope by voltage variations, we changed the concentrations of extraluminal K+. Reduction of the K+ concentration (by N-methyl-d-glucamine replacement) and the ensuing change in the K+ electrochemical gradient led to a corresponding Ca2+ discharge (Fig. 3D). Tolbutamide failed to produce a Ca2+ transient in nuclei pretreated with 10 μM of the K+ ionophore valinomycin, further suggesting that the collapse of K+ electrochemical gradient can suppress Ca2+ release (data not shown). We monitored changes of nuclear transmembrane potential (ΔΨn) by using DiOC6(3), which has been validated as a potentiometric probe in mitochondria (ref. 19; see Materials and Methods). DiOC6(3) accumulated in the nuclear envelope of beta cells. Tolbutamide elicited a consistent increase in DiOC6(3) fluorescence, indicating that the perinuclear lumen became more negative (Fig. 3E). These results pointed to the existence of a ΔΨn, which may change as a result of a decrease in K+ permeability. In beta cells, a [Ca2+]n pathway sensitive to this ΔΨn may exist.
Several intracellular channels found in the endo-sarcoplasmic reticulum (ER/SR) and nucleus, including inositol-1,4,5-trisphosphate receptors (InsP3-R) and ryanodine receptors (RyR; refs. 11, 14, and 32) among others, have been shown to be voltage-sensitive. Ca2+ release induced by tolbutamide decreased 81.3 ± 9.3% in isolated nuclei exposed to 10 μM ruthenium red, a RyR blocker (Fig. 3F). Higher ruthenium red concentrations (100 μM) completely blocked the Ca2+ release. Similar results were observed when isolated nuclei were preincubated with anti-RyR antibodies (1:100, 30 min; data not shown). Conversely, heparin, a blocker of the InsP3-R (15) did not produce a significant effect (data not shown).
Nuclear Function of nKATP Channels.
Several roles have been suggested for nuclear channels, yet very few studies relate these channels to nuclear functions. As has recently been proposed, nuclear Ca2+ signals may target the CREB protein, whose phosphorylation may activate transcription (20, 33). By using immunofluorescence in isolated functional nuclei (20), we have observed CREB phosphorylation (Fig. 4) induced by tolbutamide and AP4A, both KATP blockers that provoked an increase of [Ca2+]n (Fig. 3). As shown in Fig. 1D, the KATP channel opener diazoxide counteracted the tolbutamide effects (Fig. 4D). These observations further suggested that the closure of nKATP channels initiate the transduction of nuclear signals.
Figure 4.

CREB phosphorylation in isolated nuclei. Immunofluorescence detection of P-CREB in nuclei treated with different stimuli. (A) Ca2+ (1 μM). (B) Tolbutamide (100 μM). (C) Ca2+ (65 nM). Immunodetection is shown in green, and ethidium homodimer-1 staining is shown in red. (D) Percentage of labeled nuclei relative to the maximal response 1 μM Ca2+ (HC; n = 145) measured in the following conditions: 100 μM tolbutamide (T; n = 112); 100 μM tolbutamide plus 200 μM diazoxide (T+D; n = 92); 100 μM AP4A (n = 56); and 65 nM Ca2+ (LC; n = 134).
In addition to transcription factors, other specific intranuclear Ca2+ targets may exist that regulate specific nuclear events, such as gene induction. These targets might include nuclear kinases, polymerases and chromatin remodeling, among others (34). To evaluate the relationship between these nuclear Ca2+ signals and gene expression, we conducted fluorescence in situ hybridization experiments in intact beta cells. C-myc expression was chosen as a model because this immediate early gene is activated by glucose in a Ca2+-dependent manner in both cultured cell lines (21; E.R., unpublished work) and in islet cells (35). Fig. 5 shows c-myc expression in islet cells under different stimuli. Remarkably, tolbutamide and AP4A activated gene expression (30 and 20%, respectively) even in the absence of extracellular Ca2+. In this condition, both KATP blockers induced Ca2+ changes within the nuclear space (Figs. 1C and 3 A–C). Diazoxide abolished these effects when present (data not shown).
Figure 5.

Gene expression induced by KATP channel blockers in the absence of extracellular Ca2+. Fluorescence in situ hybridization and transmitted light images of islet cells stimulated in different conditions. (A) Glucose (16 mM). (B) Tolbutamide (100 μM) in the absence of extracellular Ca2+ (buffered with EGTA). (C) Glucose (3 mM) as a control condition. The green color shows c-myc expression of beta cells counterstained with ethidium homodimer (red). (Bar = 10 μm.) (D) Percentage of activated cells relative to unstimulated control cells (3 mM glucose; n = 360) in different conditions: 40 mM potassium (K+; n = 290); 16 mM glucose (G; n = 369); 100 μM tolbutamide (T; n = 329); 100 μM tolbutamide in the absence of extracellular Ca2+ [T(0); n = 466]; 100 μM AP4A in the absence of extracellular Ca2+ (n = 105); and absence of extracellular Ca2+ [Ca2+(0); n = 211]. Results were pooled from three independent experiments. β-actin constitutive expression was used as an invariable control under the same conditions.
Discussion
Exposure of beta cells to glucose results in a Ca2+-mediated activation of a broad range of functions (3–6). However, the link between glucose-induced Ca2+ signals and specific organelles remains obscure. Here, we focused on the mechanism of glucose-regulated [Ca2+]n fluctuations and the effect of these Ca2+ signals on nuclear function. Exposure of intact cells to glucose and tolbutamide led to a [Ca2+]n rise both in cells equilibrated in normal Krebs–Ringer containing 2.5 mM Ca2+ and in Ca2+-free Krebs–Ringer solution (Fig. 1 B and C). These results suggest that both secretagogues must be acting on intracellular Ca2+ compartments and are in agreement with previous observations in beta cells (36) showing that tolbutamide can increase cytosolic [Ca2+] in the absence of extracellular Ca2+. Mitochondria have been suggested as an intracellular target of sulfonylureas in beta cells (36). However, the intracellular source of this sulfonylurea-induced Ca2+ release was not univocally identified. Although Ca2+ discharge from an organelle could diffuse to the nuclear space, our observations that tolbutamide can increase [Ca2+]n as well in permeabilized cells equilibrated in Ca2+-buffered intracellular medium (Fig. 1D), indicate that in this case the source of Ca2+ may be located very close to the nucleus. This tolbutamide effect was readily blocked by diazoxide, a KATP channel opener (Fig. 1D). This observation indicates that KATP channels may be present near the nucleus and their closure may control [Ca2+]n in beta cells. Excised patches of nuclear membrane confirmed the presence of a nuclear nKATP channel that exhibits kinetics and pharmacological properties very similar to the KATP channels found in the plasma membrane (ref. 25; Fig. 2I). Patch scission can provoke membrane remodeling, making it difficult to know the channel orientation by using the patch-clamp approach. However, the effect of the membrane-impermeant KATP channel blocker AP4A (2) on Ca2+ release in isolated nuclei (Fig. 3D) suggests that the regulatory site of this channel is not facing the perinuclear space.
In addition to this functional characterization we have demonstrated here a specific binding site for sulfonylureas at the beta cell nuclear envelope (Fig. 2) that was revealed by glibenclamide-BODIPY-FL binding. This method has been successfully used to detect the presence of KATP channels in different kinds of cells including beta cells, neurons, and monocytes (15). Our results are in agreement with previous work in cells transfected with green fluorescent protein-tagged constructs linked to SUR1 or Kir6.2 that showed fluorescence patterns not only in plasma but in perinuclear membranes, as well as in ER and Golgi (30, 31). Thus, three independent lines of evidence point to the presence of a KATP channel in the nuclear envelope, broadening the idea that together with the well characterized plasma membrane KATP channels (24, 25), sulfonylureas might have multiple sites of action (26), including mitochondria (27), secretory granules (28, 29), and, as shown here, the nuclear envelope.
Our results show that nKATP channels are involved in beta cell nuclear Ca2+ signaling because specific KATP blockers such as tolbutamide (25) and AP4A (2) induced Ca2+ release from the nuclear envelope to the nucleoplasm in isolated nuclei (Fig. 3 A–C). Several lines of evidence suggest that the nuclear Ca2+ pathway revealed here depends on a change in K+ permeability and ΔΨn in beta cell nuclei. First, valinomycin abolished tolbutamide-induced Ca2+ transients. Second, a change in K+ electrochemical gradient by NMG+ replacement in the extraluminal medium produced a similar Ca2+ discharge (Fig. 3D). Third, tolbutamide provoked a transient increase in ΔΨn (Fig. 3E) as revealed the voltage-sensor DiOC6(3) (19, 37). It is plausible that a potential difference between perinuclear space and cytosol exists because the two membranes of the nuclear envelope surround a lumen that separates different subcellular compartments and contains a diversity of channels with different permeabilities (23, 34). The nuclear envelope is a structural extension of the ER/SR network. Thus, similar properties and molecular composition are shared among these organelles. The existence of a low resting transmembrane potential described in the SR (38) is compatible with transient voltage increases during stimulation similar to those reported here.
Although the understanding of the molecular components of the nuclear envelope and their regulation have undergone important progress, their involvement in nuclear Ca2+ signaling still remains a challenge for exploration (23, 34). A variety of ER/SR and nuclear channels that may contribute to regulate [Ca2+]n and other ion species have been reported (13, 32, 39–44). An important feature is that several ER/SR and nuclear channels are voltage-sensitive. Those include Cl− (13), K+ (42), RyR (32), InsP3-R (14), and InsP3-insensitive Ca2+ channels (43, 44). Our results are consistent with RyR channels at the nuclear envelope—as observed in exocrine cells (11) and oocytes (45)—that may control the nuclear Ca2+ release reported here, because their blockade by ruthenium red or anti-RyR antibodies suppressed the tolbutamide-induced nuclear Ca2+ transients (Fig. 3F). It is noteworthy that RyR channels undergo an active state of elevated open probability upon changes of voltage (32). Thus, it is very likely that RyR channels may be affected by tolbutamide-induced nuclear voltage changes (Fig. 3E). Their activation may lead to Ca2+-release, which may be amplified by a Ca2+-induced Ca2+-release process, as has been observed in ER of pancreatic beta cells (46).
Our results show that this tolbutamide-induced [Ca2+]n conductance seems to be associated with a change in ΔΨn as a result of a decrease in K+ permeability (Fig. 3 D and E). This process is not exclusive to beta cells. In fact, there is a body of evidence that establishes a link between K+ and Ca2+ conductances in the ER/SR. For instance, Ca2+ release from SR has been induced not only by K+ channel general blockers (47) but also by the specific KATP channel blocker glibenclamide (48), suggesting the presence of this K+ channel type and its role in intracellular Ca2+ release. Moreover, lowering the extraluminal K+ produced a Ca2+ discharge from SR microsomes of myocytes, suggesting a voltage change that is not explained well by current ideas about E–C coupling in muscle cells (49). Furthermore, a functional KATP channel has been proposed to control the K+ permeability and the granular membrane potential in glucagon-containing secretory granules (29). The presence of nuclear Ca2+ channels sensitive to changes in transmembrane potential explains tolbutamide-induced Ca2+ release in beta cell nuclei. Nonetheless, we do not exclude the involvement of other voltage-sensitive pathways that may direct or indirectly trigger the nuclear Ca2+ release reported here. These possible pathways may include ion exchange fluxes coupled to Ca2+ (50, 51) or other mechanisms such as the ER Ca2+ leak pathway (52). In fact, a remarkable characteristic is that the ER leak pathway is increased with high concentrations of ATP, a blocker of the KATP channel (52). In summary, we suggest that blockade of KATP channels at the nuclear envelope may elicit a transient transmembrane potential rise as a result of K+ permeability decrease, which may trigger a voltage-sensitive Ca2+ discharge, mainly through RyR channels.
By using immunofluorescence, we have proved that the nuclear Ca2+ transients reported here increased the phosphorylation rate of the transcription factor CREB (Fig. 4) in isolated nuclei, in agreement with similar results described in hippocampal neuron nuclei (20). Our working model only allows Ca2+ mobilization from the nucleus and unambiguously involves nKATP channels in pancreatic beta cell nuclear function.
In a whole-cell model, we evaluated the possibility of other nuclear processes such as gene expression being affected. Tolbutamide and AP4A, which induced Ca2+ release in isolated nuclei (Fig. 3), triggered c-myc expression in the absence of extracellular Ca2+ (Fig. 5). In the whole cell, we cannot rule out the possibility that other Ca2+ release in the cytosol may drive gene expression in our conditions. However, as shown here, the nucleus probably accounts for an important part of these intracellular Ca2+ signals (Figs. 1 and 3). Be that as it may, we have demonstrated that these nuclear Ca2+ signals are sufficient to drive CREB phosphorylation in isolated nuclei in these cells. Hence, Ca2+ signals generated at the nuclear envelope have an important role for nuclear function in beta cells.
We propose that signals generated by glucose metabolism not only inhibit the plasma membrane KATP channel, initiating insulin release, but also interact with nKATP channels, triggering nuclear Ca2+ signals that modulate nuclear functions such as phosphorylation of the transcription factor CREB and likely gene expression. Our data shows a new signal-transduction pathway linking nuclear K+ ion channels to fluctuations of [Ca2+]n and nuclear function and also contributes to an understanding of the mechanism of action of sulfonylureas, drugs that are broadly used in the clinic for the treatment of the diabetic patient.
Acknowledgments
We thank P. Verdugo and D. Willows for the critical review of the manuscript. This work was supported in part by Grant PM99-0142 from Secretaría de Estado de Universidades e Investigación, Fundació Marató TV3 Grant 99-1210, Fundación Salud 2000, Juvenile Diabetes Foundation Grant 1-2000-575, and Generalitat Valenciana Grant GV99- 139-1-04.
Abbreviations
- KATP
ATP-sensitive K+ channel
- [Ca2+]n
nuclear Ca2+ concentration
- CREB
cAMP response element binding protein
- RT
room temperature
- BODIPY
dipyrrometheneboron difluoride
- nKATP
nuclear KATP channel
- ER
endoplasmic reticulum
- ER/SR
endo-sarcoplasmic reticulum
- RyR
ryanodine receptors
Footnotes
This paper was submitted directly (Track II) to the PNAS office.
References
- 1.Prentki M, Matchinsky F M. Physiol Rev. 1987;67:1185–1248. doi: 10.1152/physrev.1987.67.4.1185. [DOI] [PubMed] [Google Scholar]
- 2.Martin F, Pintor J, Rovira J M, Miras-Portugal M C, Soria B. FASEB J. 1998;12:1499–1506. doi: 10.1096/fasebj.12.14.1499. [DOI] [PubMed] [Google Scholar]
- 3.Valdeolmillos M, Nadal A, Contreras D, Soria B. J Physiol. 1992;455:173–186. doi: 10.1113/jphysiol.1992.sp019295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Santos R M, Rosario L M, Nadal A, Garcia-Sancho J, Soria B, Valdeolmillos M. Pflügers Arch. 1991;418:417–422. doi: 10.1007/BF00550880. [DOI] [PubMed] [Google Scholar]
- 5.Berridge M J, Bootman M D, Lipp P. Nature (London) 1997;386:759–760. [Google Scholar]
- 6.Roche E, Prentki M. Cell Calcium. 1994;16:331–338. doi: 10.1016/0143-4160(94)90097-3. [DOI] [PubMed] [Google Scholar]
- 7.Susini S, Roche E, Prentki M, Schlegel W. FASEB J. 1997;12:1173–1182. [PubMed] [Google Scholar]
- 8.Martin F, Moya F, Gutierrez L M, Reig J A, Soria B. Diabetologia. 1995;38:860–863. doi: 10.1007/s001250050364. [DOI] [PubMed] [Google Scholar]
- 9.Quesada I, Martin F, Soria B. J Physiol. 2000;525:159–167. doi: 10.1111/j.1469-7793.2000.t01-1-00159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Escobar A L, Monck J R, Fernandez J M, Vergara J L. Nature (London) 1994;367:739–741. doi: 10.1038/367739a0. [DOI] [PubMed] [Google Scholar]
- 11.Gerasimenko O V, Gerasimenko J V, Belan P V, Petersen O H. Cell. 1995;80:439–444. doi: 10.1016/0092-8674(95)90494-8. [DOI] [PubMed] [Google Scholar]
- 12.Radominska-Pandya A, Pokrovskaya I D, Xu J, Little J M, Jude A R, Kurten R C, Czernik P J. Arch Biochem Biophys. 2002;399:37–48. doi: 10.1006/abbi.2001.2743. [DOI] [PubMed] [Google Scholar]
- 13.Tabares L, Mazzanti M, Clapham D E. J Membrane Biol. 1991;123:49–54. doi: 10.1007/BF01993962. [DOI] [PubMed] [Google Scholar]
- 14.Stehno-Bittel L, Lückhoff A, Clapham D E. Neuron. 1995;14:163–167. doi: 10.1016/0896-6273(95)90250-3. [DOI] [PubMed] [Google Scholar]
- 15.Quesada I, Nadal A, Soria B. Diabetes. 1999;48:2390–2397. doi: 10.2337/diabetes.48.12.2390. [DOI] [PubMed] [Google Scholar]
- 16.Nadal A, Rovira J M, Laribi O, Leon-Quinto T, Andreu E, Ripoll C, Soria B. FASEB J. 1998;12:1341–1348. doi: 10.1096/fasebj.12.13.1341. [DOI] [PubMed] [Google Scholar]
- 17.Mazzanti M, Inocenti B, Rigatelli M. FASEB J. 1994;8:231–236. doi: 10.1096/fasebj.8.2.7509760. [DOI] [PubMed] [Google Scholar]
- 18.Nicotera P, McConkey D J, Jones D P, Orrenius S. Proc Natl Acad Sci USA. 1989;86:453–457. doi: 10.1073/pnas.86.2.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Loew L M. In: Fluorescent and Luminiscent Probes for Biological Activity. Mason W T, editor. San Diego: Academic; 1993. pp. 150–160. [Google Scholar]
- 20.Hardigham G E, Arnold F J L, Bading H. Nat Neurosci. 2001;4:261–267. doi: 10.1038/85109. [DOI] [PubMed] [Google Scholar]
- 21.Jonas J C, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir G C. J Biol Chem. 1999;274:14112–14121. doi: 10.1074/jbc.274.20.14112. [DOI] [PubMed] [Google Scholar]
- 22.Jiang F X, Cram D S, DeAizpurua H J, Harrison L C. Diabetes. 1999;48:722–730. doi: 10.2337/diabetes.48.4.722. [DOI] [PubMed] [Google Scholar]
- 23.Santella L, Carafoli E. FASEB J. 1997;11:1091–1109. [PubMed] [Google Scholar]
- 24.Aguilar-Bryan L, Clement J P, Gonzalez G, Kunjilwar K, Babenko A. Physiol Rev. 1998;78:227–245. doi: 10.1152/physrev.1998.78.1.227. [DOI] [PubMed] [Google Scholar]
- 25.Ashcroft F M. Annu Rev Neurosci. 1988;11:97–118. doi: 10.1146/annurev.ne.11.030188.000525. [DOI] [PubMed] [Google Scholar]
- 26.Ozanne S E, Guest P C, Hutton J C, Hales C N. Diabetologia. 1995;38:277–282. doi: 10.1007/BF00400631. [DOI] [PubMed] [Google Scholar]
- 27.Holmuhamedov E L, Jovanovic S, Dzeja P P, Jovanovic A, Terzic A. Am J Physiol. 1998;275:H1567–H1576. doi: 10.1152/ajpheart.1998.275.5.H1567. [DOI] [PubMed] [Google Scholar]
- 28.Braun M, Anderie I, Thévenod F. FEBS Lett. 1997;411:255–259. doi: 10.1016/s0014-5793(97)00711-4. [DOI] [PubMed] [Google Scholar]
- 29.Hoy M, Olsen H L, Bokvist K, Buschard K, Barg S, Rorsman P, Gromada J. J Physiol (London) 2000;527.1:109–120. doi: 10.1111/j.1469-7793.2000.00109.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.John S A, Monck J R, Weiss J N, Ribalet B. J Physiol (London) 1998;510.2:333–345. doi: 10.1111/j.1469-7793.1998.333bk.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Makhina E N, Nichols C G. J Biol Chem. 1998;273:3369–3374. doi: 10.1074/jbc.273.6.3369. [DOI] [PubMed] [Google Scholar]
- 32.Zahradnikova A, Meszaros L G. J Physiol (London) 1998;509.1:29–38. doi: 10.1111/j.1469-7793.1998.029bo.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bading H. Eur J Biochem. 2000;267:5280–5283. doi: 10.1046/j.1432-1327.2000.01565.x. [DOI] [PubMed] [Google Scholar]
- 34.Rogue P J, Malviya A N. EMBO J. 1999;18:5147–5152. doi: 10.1093/emboj/18.19.5147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jonas J C, Laybutt D R, Steil G M, Trivedi N, Pertusa J G, Van de Casteele M, Weir G C, Henquin J C. J Biol Chem. 2001;276:35375–35381. doi: 10.1074/jbc.M105020200. [DOI] [PubMed] [Google Scholar]
- 36.Smith P, A, Proks P, Moorhouse A. Pflügers Arch. 1999;437:577–588. doi: 10.1007/s004240050820. [DOI] [PubMed] [Google Scholar]
- 37.Raraty M, Ward J, Erdemli G, Vaillant C, Neoptolemos J P, Sutton R, Petersen O H. Proc Natl Acad Sci USA. 2000;97:13126–13131. doi: 10.1073/pnas.97.24.13126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Somlyo A V, Gonzalez-Serratos H, Schuman H, McClellan G, Somlyo A P. J Cell Biol. 1981;90:577–594. doi: 10.1083/jcb.90.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Franco-Obregon A, Wang H W, Clapham D E. Biophys J. 2000;79:202–214. doi: 10.1016/S0006-3495(00)76284-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mazzanti M, DeFelice L J, Cohen J, Malter H. Nature (London) 1990;343:764–767. doi: 10.1038/343764a0. [DOI] [PubMed] [Google Scholar]
- 41.Longin A S, Mezin P, Favier A, Verdetti J. Biochem Biophys Res Commun. 1997;235:236–241. doi: 10.1006/bbrc.1997.6752. [DOI] [PubMed] [Google Scholar]
- 42.Guilhard G, Proteau S, Payet M D, Escande D, Rousseau E. FEBS Lett. 2000;476:234–239. doi: 10.1016/s0014-5793(00)01752-x. [DOI] [PubMed] [Google Scholar]
- 43.Martin C, Ashley R H. Cell Calcium. 1993;14:427–438. doi: 10.1016/0143-4160(93)90002-n. [DOI] [PubMed] [Google Scholar]
- 44.Schmid A, Dehlinger-Kremer M, Schulz I, Gogelein H. Nature (London) 1990;346:374–376. doi: 10.1038/346374a0. [DOI] [PubMed] [Google Scholar]
- 45.Santella L, Kyozuka K. Cell Calcium. 1997;22:11–20. doi: 10.1016/s0143-4160(97)90085-3. [DOI] [PubMed] [Google Scholar]
- 46.Lemmens R, Larsson O, Berggren P O, Islam M S. J Biol Chem. 2001;276:9971–9977. doi: 10.1074/jbc.M009463200. [DOI] [PubMed] [Google Scholar]
- 47.Ishida Y, Honda H, Watanabe T X. Br J Pharmacol. 1992;106:764–765. doi: 10.1111/j.1476-5381.1992.tb14409.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Chopra L C, Charles H C T, Ward J P T. Br J Pharmacol. 1992;105:259–260. doi: 10.1111/j.1476-5381.1992.tb14242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Endo M. Curr Top Membr Transp. 1985;25:181–230. [Google Scholar]
- 50.Patel J R, Sukhareva M, Coronado R, Moss R. J Membr Biol. 1996;154:81–89. doi: 10.1007/s002329900134. [DOI] [PubMed] [Google Scholar]
- 51.Pozzan T, Rizzuto R, Volpe P, Meldolesi J. Physiol Rev. 1994;74:595–636. doi: 10.1152/physrev.1994.74.3.595. [DOI] [PubMed] [Google Scholar]
- 52.Hofer A M, Curci S, Machen T E, Schulz I. FASEB J. 1996;10:302–308. doi: 10.1096/fasebj.10.2.8641563. [DOI] [PubMed] [Google Scholar]

